For the year ending 2025-12-31, ELV made $199,125M in revenue. $5,662M in net income. Net profit margin of 2.84%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total revenues | 199,125 | 177,011 | 171,340 | 156,595 |
| Total net incurred medical claims | - | 123,639 | - | - |
| Quality improvement and other claims expense | - | 3,928 | - | - |
| Benefit expense | 148,223 | 127,567 | 124,330 | 116,487 |
| Cost of products sold | 21,178 | 19,750 | 17,293 | 13,035 |
| Operating expense | 20,984 | 20,025 | 20,087 | 17,686 |
| Interest expense | 1,402 | 1,185 | 1,030 | 851 |
| Amortization of other intangible assets | 628 | 580 | 885 | 767 |
| Loss on extinguishment of debt | - | - | 0 | 0 |
| Total expenses | 192,415 | 169,107 | 163,625 | 148,826 |
| Income before income tax expense | 6,710 | 7,904 | 7,715 | 7,769 |
| Income tax expense | 1,049 | 1,933 | 1,724 | 1,750 |
| Net income | 5,661 | 5,971 | 5,991 | 6,019 |
| Net loss (gain) attributable to noncontrolling interests | -1 | -9 | 4 | -6 |
| Shareholders net income | 5,662 | 5,980 | 5,987 | 6,025 |
| Basic EPS | 25.28 | 25.81 | 25.38 | 25.1 |
| Diluted EPS | 25.21 | 25.68 | 25.22 | 24.81 |
| Basic Average Shares | 224,000,000 | 231,700,000 | 235,900,000 | 240,000,000 |
| Diluted Average Shares | 224,600,000 | 232,900,000 | 237,400,000 | 242,800,000 |
Elevance Health, Inc. (ELV)
Elevance Health, Inc. (ELV)